Yu-Chun Chang

Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway

Ray-Jade Chen, W. Kuo, C. Kuo, 2022, Journal of hypertension.

Calreticulin nuclear translocalization alleviates CaM/CaMKII/CREB signaling pathway to enhance chemosensitivity in HDAC inhibitor-resistant hepatocellular carcinoma cells

W. Kuo, Chih-Yang Huang, Ming-Cheng Chen, 2022, Aging.

Daidzein Synergizes with Gefitinib to Induce ROS/JNK/c-Jun Activation and Inhibit EGFR-STAT/AKT/ERK Pathways to enhance Lung Adenocarcinoma cells chemosensitivity

T. Shih, Ray-Jade Chen, W. Kuo, 2022, International journal of biological sciences.

Rapid Detection of Gut Microbial Metabolite Trimethylamine N-Oxide for Chronic Kidney Disease Prevention

Y. Tain, Hung-Wei Yang, Yu-Chun Chang, 2021, Biosensors.

MicroRNA-221/222 Mediates ADSC-Exosome-Induced Cardioprotection Against Ischemia/Reperfusion by Targeting PUMA and ETS-1

Shu-Wha Lin, Yuh-Lien Chen, Jaw-Shiun Tsai, 2020, Frontiers in Cell and Developmental Biology.

A randomized controlled trial of auricular acupressure in heart rate variability and quality of life for hypertension.

Tso-Ying Lee, Yi-Ying Huang, Yu-Chun Chang, 2015, Complementary therapies in medicine.

Inhibition of Protein Phosphatase 1 Stimulates Noncanonical ER Stress eIF2α Activation to Enhance Fisetin-induced Chemosensitivity in HDAC Inhibitor-resistant Hepatocellular Carcinoma Cells

W. Kuo, V. Viswanadha, Chih-Yang Huang, 2019, Cancers.

Aloin and CPT-11 combination activates miRNA-133b and downregulates IGF1R- PI3K/AKT/mTOR and MEK/ERK pathways to inhibit colorectal cancer progression.

W. Kuo, Tsung‐Jung Ho, Ming-Cheng Chen, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A randomized controlled trial of auricular acupressure in heart rate variability and quality of life for hypertension.

Tso-Ying Lee, Yi-Ying Huang, Yu-Chun Chang, 2015, Complementary therapies in medicine.